The Senhance™ surgical robotic system (“Senhance”) for total hysterectomy in obese patients: a pilot study

The Senhance™ surgical robotic system (“Senhance”) for total hysterectomy in obese... This pilot study was aimed to value the feasibility and safety of Senhance Robotic Platform for hysterectomy in obese patients. Ten obese patients (30 < BMI < 40) underwent elective Senhance total extrafascial hysterectomy with bilateral salpingo-oophorectomy at the Division of Gynecologic Oncology of “Policlinico A. Gemelli” Foundation, Rome, Italy. Perioperative and postoperative outcomes data were recorded. The median age was 60 years (range 51–75) and the median BMI was 33.3 kg/m2 (range 30.4–38.3). The median uterine weight was 112.5 g (range 77–225). Indication to total hysterectomy was early-stage (FIGO Stage IA) endometrial cancer in 100% of patients. The median operative time (OT) was 110 min (70–200). The median docking time was 10.5 min (5–25). The median estimated blood loss was 100 mL (50–200). No conversions to laparotomy were recorded. No intra- and 30-day postoperative complications were registered. The median ileus was 17 h (12–36) and the median time to discharge was 2 days (1–4). The median VAS scores registered at 2, 4, 12, and 24 h were, respectively, 2 (1–3), 2 (1–3), 4 (1–8), and 3 (1–5). Our study results suggest that Senhance platform could be safe for hysterectomy even in obese patients. More clinical data are needed to determine whether this approach would offer any additional benefits in a new middle line between standard laparoscopy and robotics. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Robotic Surgery Springer Journals

The Senhance™ surgical robotic system (“Senhance”) for total hysterectomy in obese patients: a pilot study

Loading next page...
 
/lp/springer_journal/the-senhance-surgical-robotic-system-senhance-for-total-hysterectomy-n3QIji0nEi
Publisher
Springer London
Copyright
Copyright © 2017 by Springer-Verlag London Ltd.
Subject
Medicine & Public Health; Minimally Invasive Surgery; Surgery; Urology
ISSN
1863-2483
eISSN
1863-2491
D.O.I.
10.1007/s11701-017-0718-9
Publisher site
See Article on Publisher Site

Abstract

This pilot study was aimed to value the feasibility and safety of Senhance Robotic Platform for hysterectomy in obese patients. Ten obese patients (30 < BMI < 40) underwent elective Senhance total extrafascial hysterectomy with bilateral salpingo-oophorectomy at the Division of Gynecologic Oncology of “Policlinico A. Gemelli” Foundation, Rome, Italy. Perioperative and postoperative outcomes data were recorded. The median age was 60 years (range 51–75) and the median BMI was 33.3 kg/m2 (range 30.4–38.3). The median uterine weight was 112.5 g (range 77–225). Indication to total hysterectomy was early-stage (FIGO Stage IA) endometrial cancer in 100% of patients. The median operative time (OT) was 110 min (70–200). The median docking time was 10.5 min (5–25). The median estimated blood loss was 100 mL (50–200). No conversions to laparotomy were recorded. No intra- and 30-day postoperative complications were registered. The median ileus was 17 h (12–36) and the median time to discharge was 2 days (1–4). The median VAS scores registered at 2, 4, 12, and 24 h were, respectively, 2 (1–3), 2 (1–3), 4 (1–8), and 3 (1–5). Our study results suggest that Senhance platform could be safe for hysterectomy even in obese patients. More clinical data are needed to determine whether this approach would offer any additional benefits in a new middle line between standard laparoscopy and robotics.

Journal

Journal of Robotic SurgerySpringer Journals

Published: Jun 17, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off